Abstract
Heavy menstrual bleeding is the most common sign of an acquired or inherited bleeding disorder in females. For many young women, the manifestations of an inherited bleeding disorder do not surface until menarche, which can lead to a delay in diagnosis. Besides heavy menstrual bleeding, patients can have menstrual pain from bleeding into the corpus luteum, bleeding from trauma or procedures, easy bruising, and gastrointestinal bleeding. An undiagnosed bleeding disorder can lead to severe blood loss, chronic iron deficiency, and unnecessary surgical procedures, such as a hysterectomy. Therefore, identifying a possible bleeding disorder in these young women is crucial to allow an initiation of targeted therapy. Management of bleeding will depend on the diagnosis, as well as the severity and bleeding location. Many adolescent females with menorrhagia can be successfully managed with a combination of hormonal control and/or antifibrinolytics. Depending on the diagnosis, treatment can also include coagulation factor replacement, blood product transfusion, as well as specific therapies for acquired bleeding disorders, such as intravenous immune globulin, plasmapheresis, or corticosteroids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia. 2008;14(6):1151–8.
Acharya SS, Coughlin A, Dimichele DM. G. North American rare bleeding disorder study. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004;2(2):248–56.
Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. F. I. X. Subcommittee on factor Viii, S. rare coagulation disorders of the, T. Standardization Committee of the International Society on and hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12(11):1935–9.
British Committee for Standards in Haematology General Haematology Task, F. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574–96.
Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133(4):364–74.
Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. J Thromb Haemost. 2007;5(Suppl 1):95–101.
Dhawan A. Acute liver failure in children and adolescents. Clin Res Hepatol Gastroenterol. 2012;36(3):278–83.
Escolar G, Diaz-Ricart M, Cases A. Uremic platelet dysfunction: past and present. Curr Hematol Rep. 2005;4(5):359–67.
Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001;98(6):1662–6.
Gale AJ. Continuing education course #2: current understanding of hemostasis. Toxicol Pathol. 2011;39(1):273–80.
Halimeh S, Rott H, Kappert G. PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding. Haemophilia. 2016;22(3):e217–20.
Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734–9.
Israels SJ, El-Ekiaby M, Quiroga T, Mezzano D. Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding. Haemophilia. 2010;16(Suppl 5):152–9.
Israels SJ, Kahr WH, Blanchette VS, Luban NL, Rivard GE, Rand ML. Platelet disorders in children: a diagnostic approach. Pediatr Blood Cancer. 2011;56(6):975–83.
James AH. Women and bleeding disorders. Haemophilia. 2010;16(Suppl 5):160–7.
James AH, Ragni MV, Picozzi VJ. Bleeding disorders in premenopausal women: (another) public health crisis for hematology? Hematol Am Soc Hematol Educ Program. 2006;2006:474–85.
Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485–9.
Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006;19(4):317–22.
Khamees D, Klima J, O’Brien SH. Population screening for von Willebrand disease in adolescents with heavy menstrual bleeding. J Pediatr. 2015;166(1):195–7.
Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–61.
Knol HM, Kemperman RF, Kluin-Nelemans HC, Mulder AB, Meijer K. Haemostatic variables during normal menstrual cycle. A systematic review. Thromb Haemost. 2012;107(1):22–9.
Konkle BA. Acquired disorders of platelet function. Hematol Am Soc Hematol Educ Program. 2011;2011:391–6.
Kouides PA. Bleeding symptom assessment and hemostasis evaluation of menorrhagia. Curr Opin Hematol. 2008;15(5):465–72.
Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488–94.
Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost. 2009;35(4):400–6.
Mills HL, Abdel-Baki MS, Teruya J, Dietrich JE, Shah MD, Mahoney D Jr, Yee DL, Srivaths LV. Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia. 2014;20(2):249–54.
O’Brien SH. Common management issues in pediatric patients with mild bleeding disorders. Semin Thromb Hemost. 2012;38(7):720–6.
Pai M, Hayward CP. Diagnostic assessment of platelet disorders: what are the challenges to standardization? Semin Thromb Hemost. 2009;35(2):131–8.
Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125(13):2052–61.
Peake IR, Lillicrap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K, et al. Haemophilia: strategies for carrier detection and prenatal diagnosis. Bull World Health Organ. 1993;71(3–4):429–58.
Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol. 2011;204(3):209 e201–7.
Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH, van Amstel HK, van der Bom JG, van Diemen-Homan JE, Willemse J, Rosendaal FR. Bleeding in carriers of hemophilia. Blood. 2006;108(1):52–6.
Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood. 2009;114(23):4777–83.
Rae C, Furlong W, Horsman J, Pullenayegum E, Demers C, St-Louis J, Lillicrap D, Barr R. Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life. Haemophilia. 2013;19(3):385–91.
Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood. 1987;69(2):454–9.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–93.
Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res. 2007;120(Suppl 1):S5–9.
Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost. 2009;7(Suppl 1):84–7.
Seravalli V, Linari S, Peruzzi E, Dei M, Paladino E, Bruni V. Prevalence of hemostatic disorders in adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol. 2013;26(5):285–9.
Sokkary NA, Venkateswaran L, Dietrich JE, Teruya J. Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis. J Pediatr Adolesc Gynecol. 2012;25(4):233–7.
van Ommen CH, Peters M. The bleeding child. Part I: primary hemostatic disorders. Eur J Pediatr. 2012;171(1):1–10.
Vo KT, Grooms L, Klima J, Holland-Hall C, O’Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013;19(1):71–5.
Witmer CM, Lambert MP, O’Brien SH, Neunert C. Multicenter cohort study comparing U.S. management of inpatient pediatric immune thrombocytopenia to current treatment guidelines. Pediatr Blood Cancer. 2016;63(7):1227–31.
Wolberg AS, Mast AE. Tissue factor and factor VIIa – hemostasis and beyond. Thromb Res. 2012;129(Suppl 2):S1–4.
Young G, Wicklund B, Neff P, Johnson C, Nugent DJ. Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. Pediatr Blood Cancer. 2009;53(2):179–83.
Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol. 2003;98(6):1391–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Jaffray, J., Haley, K. (2023). Management of Abnormal Bleeding in the Adolescent. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_84
Download citation
DOI: https://doi.org/10.1007/978-3-031-14881-1_84
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14880-4
Online ISBN: 978-3-031-14881-1
eBook Packages: MedicineReference Module Medicine